S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
Is This The End of Capitalism? (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
Is This The End of Capitalism? (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
Is This The End of Capitalism? (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
Is This The End of Capitalism? (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
NASDAQ:GBT

Global Blood Therapeutics - GBT SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$68.49
$68.49
50-Day Range
$68.07
$68.49
52-Week Range
$21.65
$73.02
Volume
74 shs
Average Volume
2.07 million shs
Market Capitalization
$4.62 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$65.42

Recent Global Blood Therapeutics SEC Filings

DateFilerForm TypeView
10/06/2022
3:20 PM
Global Blood Therapeutics (Issuer)
PIERCE GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:20 PM
Global Blood Therapeutics (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:20 PM
Global Blood Therapeutics (Issuer)
Pizzo Philip A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:20 PM
Global Blood Therapeutics (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:20 PM
Global Blood Therapeutics (Issuer)
Thompson Alexis A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:20 PM
Global Blood Therapeutics (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:20 PM
Global Blood Therapeutics (Issuer)
PATRICK DEVAL L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:21 PM
Global Blood Therapeutics (Issuer)
PERRY MARK L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:15 PM
Global Blood Therapeutics (Issuer)
SUVARI TRICIA BORGA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:15 PM
Farrow Jeffrey S (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:15 PM
Global Blood Therapeutics (Issuer)
Krehlik Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:15 PM
Global Blood Therapeutics (Issuer)
Habibizad Nazila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:15 PM
Global Blood Therapeutics (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:15 PM
Choi Jung (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:15 PM
Global Blood Therapeutics (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
3:15 PM
Global Blood Therapeutics (Issuer)
Smith-Whitley Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2022
3:06 PM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2022
3:06 PM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2022
7:45 PM
Global Blood Therapeutics (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2022
7:47 PM
Global Blood Therapeutics (Issuer)
Habibizad Nazila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2022
7:48 PM
Farrow Jeffrey S (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2022
7:43 PM
Choi Jung (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2022
3:17 PM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2022
6:00 PM
Global Blood Therapeutics (Issuer)
SUVARI TRICIA BORGA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
6:00 PM
Choi Jung (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
6:00 PM
Farrow Jeffrey S (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
6:00 PM
Global Blood Therapeutics (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
6:00 PM
Global Blood Therapeutics (Issuer)
Krehlik Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
6:00 PM
Global Blood Therapeutics (Issuer)
Smith-Whitley Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
6:00 PM
Global Blood Therapeutics (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
6:00 PM
Global Blood Therapeutics (Issuer)
Habibizad Nazila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
11:31 AM
Global Blood Therapeutics (Issuer)
Habibizad Nazila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2022
5:56 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2022
6:01 AM
Global Blood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2022
5:00 PM
Farrow Jeffrey S (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
5:01 PM
Global Blood Therapeutics (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
5:01 PM
Choi Jung (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
5:01 PM
Global Blood Therapeutics (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
5:01 PM
Global Blood Therapeutics (Issuer)
Habibizad Nazila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
5:01 PM
Global Blood Therapeutics (Issuer)
SUVARI TRICIA BORGA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2022
5:00 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2022
9:05 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2022
7:02 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2022
5:00 PM
Global Blood Therapeutics (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2022
5:00 PM
Global Blood Therapeutics (Issuer)
Pizzo Philip A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:38 PM
Global Blood Therapeutics (Issuer)
PERRY MARK L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:00 PM
Global Blood Therapeutics (Issuer)
PATRICK DEVAL L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:00 PM
Global Blood Therapeutics (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:00 PM
Global Blood Therapeutics (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:00 PM
Global Blood Therapeutics (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:01 PM
Global Blood Therapeutics (Issuer)
Thompson Alexis A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:01 PM
Global Blood Therapeutics (Issuer)
Pizzo Philip A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
5:01 PM
Global Blood Therapeutics (Issuer)
PIERCE GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2022
3:02 PM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2022
7:01 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2022
5:10 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2022
7:02 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2022
4:06 PM
Global Blood Therapeutics (Issuer)
Smith-Whitley Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
9:01 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2022
3:09 PM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2021
7:00 PM
Global Blood Therapeutics (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2021
7:02 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2021
7:00 PM
Global Blood Therapeutics (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2021
7:00 PM
Farrow Jeffrey S (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2021
7:00 PM
Global Blood Therapeutics (Issuer)
SUVARI TRICIA BORGA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2021
7:01 PM
Global Blood Therapeutics (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2021
7:01 PM
Choi Jung (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2021
7:00 PM
Global Blood Therapeutics (Issuer)
Krehlik Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
6:07 PM
Global Blood Therapeutics (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
5:29 PM
Choi Jung (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
5:07 PM
Global Blood Therapeutics (Issuer)
SUVARI TRICIA BORGA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
5:09 PM
Global Blood Therapeutics (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
5:15 PM
Global Blood Therapeutics (Issuer)
Krehlik Carrie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/22/2021
6:01 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2021
3:31 PM
Global Blood Therapeutics (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
3:18 PM
Brown Willie L. Jr. (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
3:11 PM
Global Blood Therapeutics (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:01 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2021
5:05 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2021
7:02 PM
Global Blood Therapeutics (Issuer)
Smith-Whitley Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
9:01 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
4:38 PM
Fink Eric (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:08 PM
Global Blood Therapeutics (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
6:05 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2021
6:00 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2021
7:20 PM
Fink Eric (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
6:56 PM
Global Blood Therapeutics (Issuer)
SUVARI TRICIA BORGA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:00 PM
CATHERS BRIAN EDWIN (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
6:40 PM
Choi Jung (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
6:46 PM
Global Blood Therapeutics (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
6:32 PM
Farrow Jeffrey S (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
6:38 PM
Global Blood Therapeutics (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
7:00 AM
Global Blood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2021
6:36 PM
Fink Eric (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:38 PM
Global Blood Therapeutics (Issuer)
SUVARI TRICIA BORGA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:41 PM
Global Blood Therapeutics (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:30 PM
Choi Jung (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:14 PM
Farrow Jeffrey S (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
6:16 PM
Global Blood Therapeutics (Issuer)
JOHNSON DAVID LEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
5:28 PM
CATHERS BRIAN EDWIN (Reporting)
Global Blood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:GBT) was last updated on 1/29/2023 by MarketBeat.com Staff